J.Safra Asset Management Corp

Position in ABBV — AbbVie Inc.

CIK 1535293 NEW YORK, NY

Position in ABBV

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,388,801

+$67,332 QoQ

Shares Held

5,519

-9.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#2,247

of 4,153 holders

Holding Since

Mar 2022

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

J.Safra Asset Management Corp holds $13,218,561 across 10 Drug Manufacturers - General names. ABBV ranks #2 (10.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,918	$8,297,657
2	ABBV	AbbVie Inc. This page	5,519	$1,388,801
3	AMGN	Amgen Inc	3,204	$1,160,232
4	JNJ	Johnson & Johnson	4,182	$1,062,102
5	AZN	Astrazeneca PLC	3,599	$682,442
6	MRK	Merck & Co., Inc.	4,298	$552,293
7	GILD	Gilead Sciences, Inc.	275	$34,743
8	NVO	Novo Nordisk A S	428	$20,518

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,388,801	5,519	-9.2%	Shares	Sole	2026-08-06
2026-03-31	$1,321,469	6,076	-2.4%	Shares	Sole	2026-05-04
2025-12-31	$1,422,807	6,227	+12.6%	Shares	Sole	2026-02-11
2025-09-30	$1,280,416	5,530	-23.5%	Shares	Sole	2025-10-29
2025-06-30	$1,341,661	7,228	+31.5%	Shares	Sole	2025-10-29
2025-03-31	$1,151,731	5,497	+89.0%	Shares	Sole	2025-10-29
2024-12-31	$516,751	2,908	+105.8%	Shares	Sole	2025-02-06
2024-09-30	$279,039	1,413	+20.2%	Shares	Sole	2024-11-13
2024-06-30	$201,707	1,176	+318.5%	Shares	Sole	2024-07-17
2024-03-31	$51,170	281	-72.5%	Shares	Sole	2024-05-09
2023-12-31	$158,534	1,023	-20.0%	Shares	Sole	2024-02-02
2023-09-30	$190,498	1,278	0.0%	Shares	Sole	2023-11-13
2023-06-30	$172,184	1,278	0.0%	Shares	Sole	2023-08-04
2023-03-31	$203,674	1,278	0.0%	Shares	Sole	2023-05-12
2022-12-31	$206,537	1,278	+2619.1%	Shares	Sole	2023-02-10
2022-03-31	$7,619	47	—	Shares	Sole	2022-05-09
No filing history on record for this holder in this stock.